L Rousseau, M Beylot-Barry, M S Doutre, C Beylot. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultCicatrix/drug therapyFemaleFibrosisHumansImmunosuppressive Agents/administration & dosageImmunosuppressive Agents/adverse effectsImmunosuppressive Agents/therapeutic useSarcoidosis/drug therapySkin Diseases/drug therapyThalidomide/administration & dosageThalidomide/adverse effectsThalidomide/therapeutic useTreatment Outcome
Substances: See more » Immunosuppressive AgentsThalidomide
Year: 1998 PMID: 9722748 DOI: 10.1001/archderm.134.8.1045
Source DB: PubMed Journal: Arch Dermatol ISSN: 0003-987X